Glenn A. Oclassen

Glenn A. Oclassen

Keine laufenden Positionen mehr

81 Jahre
Health Technology
Consumer Services
Consumer Non-Durables

Ursprung des Netzwerks ersten Grades von Glenn A. Oclassen

EinheitArt der EinheitIndustrie
San Diego State University
19
College/University Other Consumer Services 19
Public Company Pharmaceuticals: Major 16
13
Extinct Pharmaceuticals: Major 13
12
Extinct Pharmaceuticals: Major 12
6
Extinct Pharmaceuticals: Major 6
1
Subsidiary Household/Personal Care 1

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Glenn A. Oclassen

UnternehmenSektorVerknüpfte PersonenHauptposition
Biotechnology

Thomas D. Kiley

G. Kirk Raab

Jeffrey L. Cleland

Paul Laland

Corporate Officer/Principal

Chief Executive Officer

Corporate Officer/Principal

Corporate Officer/Principal

PFIZER, INC. Pharmaceuticals: Major

G. Kirk Raab

Murray C. Maytom

Howard Welgus

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Chief Tech/Sci/R&D Officer

GERON CORPORATION Biotechnology

Daniel Bradbury

Thomas D. Kiley

Director/Board Member

Director/Board Member

MEDICIS PHARMACEUTICAL CORP Pharmaceuticals: Major

Mark Prygocki

Mitchell S. Wortzman

President

Chief Tech/Sci/R&D Officer

SALIX PHARMACEUTICALS, LTD. Pharmaceuticals: Major

Carolyn J. Logan

Rick Scruggs

David Wasserman

Chief Executive Officer

Corporate Officer/Principal

Corporate Officer/Principal

Medical Specialties

Camille Samuels

Mike Raab Raab

Corporate Officer/Principal

Corporate Officer/Principal

HUMANIGEN, INC. Biotechnology

James Healy

Charles J. Democko

Chairman

General Counsel

Pharmaceuticals: Major

Craig Ballaron

Ted White

Chief Executive Officer

President

Pharmaceuticals: Major

Dan Turner

Camille Samuels

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Dan Turner

Daniel Bradbury

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Judith Ann Hemberger

Mike Raab Raab

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

James Healy

G. Kirk Raab

Mike Raab Raab

Director/Board Member

Chairman

Corporate Officer/Principal

HYPERION THERAPEUTICS INC Pharmaceuticals: Major

James Healy

Mike Raab Raab

Chairman

Director/Board Member

Pharmaceuticals: Major

Daniel Bradbury

Howard Welgus

Chairman

Chief Tech/Sci/R&D Officer

College/University

Dennie Dyer

Howard Welgus

Undergraduate Degree

Corporate Officer/Principal

University of California, Los Angeles College/University

Peter Q. Ezzell

Reginald A. Vitek

Graduate Degree

Graduate Degree

University of Alberta College/University

Nikhilesh N. Singh

Sue Cheun Wong

Doctorate Degree

Doctorate Degree

St. Joseph's University College/University

Anthony DiTonno

Ted White

Undergraduate Degree

Masters Business Admin

University of California, Berkeley College/University

James Healy

Sharon Sakai

Fritz Bien

Undergraduate Degree

Doctorate Degree

Undergraduate Degree

University of Massachusetts College/University

Paul Manning

Sean Stalfort

Undergraduate Degree

Undergraduate Degree

Villanova University College/University

Ted White

Christopher Hayes

Undergraduate Degree

Undergraduate Degree

Investment Managers

Dan Turner

Thomas Soloway

Founder

Corporate Officer/Principal

Pharmaceuticals: Major

Susan L. Koppy

Joe Bonaccorso

Corporate Officer/Principal

Corporate Officer/Principal

Food: Meat/Fish/Dairy

Paul Manning

Sean Stalfort

Chief Executive Officer

Corporate Officer/Principal

Miscellaneous Commercial Services

Thomas D. Kiley

Peter Q. Ezzell

Corporate Officer/Principal

Corporate Officer/Principal

ASCENDIS PHARMA A/S Pharmaceuticals: Major

James Healy

Thomas Soloway

Director/Board Member

Director of Finance/CFO

Miscellaneous Commercial Services

Howard Welgus

Gary Goldenberg

Corporate Officer/Principal

Corporate Officer/Principal

PERKINS OIL & GAS, INC. Oil & Gas Production

Howard H. Hendricks

Betty N. Myers

Chief Executive Officer

Chief Executive Officer

REDHILL BIOPHARMA LTD. Pharmaceuticals: Major

Rick Scruggs

David Wasserman

Director/Board Member

Corporate Officer/Principal

Investment Managers

Paul Manning

Sean Stalfort

Chief Executive Officer

Chief Executive Officer

CANDEL THERAPEUTICS, INC. Biotechnology

Paul Manning

Sean Stalfort

Chairman

Director/Board Member

Pharmaceuticals: Major

Paul Manning

Sean Stalfort

Director/Board Member

Director/Board Member

AUDENTES THERAPEUTICS, INC. Biotechnology

James Healy

Paul Laland

Thomas Soloway

Director/Board Member

Public Communications Contact

Director of Finance/CFO

The Wharton School of the University of Pennsylvania College/University

A. Davis

Nipun Davar

Neetu Kaur Dhaliwal

Eugene Scavola

Masters Business Admin

Masters Business Admin

Undergraduate Degree

Undergraduate Degree

Pharmaceuticals: Major

Paul Manning

Sean Stalfort

Director/Board Member

Director/Board Member

BOLT BIOTHERAPEUTICS, INC. Pharmaceuticals: Major

James Healy

Kathy LaPorte

Director/Board Member

Director/Board Member

Biotechnology

Paul Manning

Sean Stalfort

Chairman

Director/Board Member

DOVA PHARMACEUTICALS, INC. Pharmaceuticals: Major

Paul Manning

Sean Stalfort

Chairman

Director/Board Member

ARCUTIS BIOTHERAPEUTICS, INC. Pharmaceuticals: Major

Howard Welgus

Patrick Burnett

Director/Board Member

Chief Tech/Sci/R&D Officer

TAYSHA GENE THERAPIES, INC. Biotechnology

Paul Manning

Sean Stalfort

Director/Board Member

Director/Board Member

TEMPEST THERAPEUTICS, INC. Pharmaceuticals: Major

Mike Raab Raab

Sharon Sakai

Chairman

General Counsel

Statistik

International

Vereinigte Staaten 48
Kanada 2
Dänemark 2
Israel 2

Sektoral

Health Technology 35
Consumer Services 9
Commercial Services 5
Finance 3
Consumer Non-Durables 2

Operativ

Director/Board Member 354
Corporate Officer/Principal 162
Independent Dir/Board Member 72
Undergraduate Degree 65
Chairman 49
  1. Börse
  2. Insiders
  3. Glenn A. Oclassen
  4. Unternehmensverbindungen
-40 % Einmalige Verlängerung: Unsere Abonnements führen Sie zu den besten Investitionen von morgen
PROFITIEREN SIE JETZT